Birthplace
ARALIK
Languages
ENGLISH
Experiences
2024 - 2025
Istinye University Bahçeşehir Hospital
2019 - 2024
Van Regional Training and Research Hospital
2014 - 2014
Silopi State Hospital
2007 - 2008
Van State Hospital
Educations
2018
Istanbul University Istanbul Faculty of Medicine, Rheumatology
2014
Istanbul University Istanbul Faculty of Medicine, Internal Medicine
2014
Istanbul University Istanbul Faculty of Medicine, Internal Medicine
2010
Atatürk University Faculty of Medicine, Cardiology - Research Assistant
2007
Uludağ University, Faculty of Medicine
Publications
1. Oğuz E, Bektaş M. Characteristics of patients with Behçet disease from the Van province, eastern Turkey: Definition of disease clusters in a tertiary referral center. J Clin Rheumatol. 2023. doi:10.1097/RHU.0000000000001996
2. Oğuz E, et al. Characteristics and course of patients with AA amyloidosis: Single centre experience with 174 patients from Turkey. Rheumatology (Oxford). 2024;63(2):319-328. doi:10.1093/rheumatology/kead465
3. Oğuz E, et al. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: A controlled study. Clin Exp Rheumatol. 2024;42(2):358-366. doi:10.55563/clinexprheumatol/9u122p
4. Bektaş M, Özer MD, Oğuz E. The safety and efficacy of TNF inhibitors in patients with Behçet's disease: Retrospective study from eastern Turkey. Clin Immunol. 2024;264:110239. doi:10.1016/j.clim.2024.110239
5. Oğuz E, Koca N, Bektaş M. Presence of myositis-specific autoantibodies may predict favorable outcomes to rituximab in patients with idiopathic inflammatory myositis: Retrospective observational study. Mod Rheumatol. 2025 (ahead of print). doi:10.1093/mr/roaf097
6. Oğuz E, et al. Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome on maintenance haemodialysis. J Clin Pharm Ther. 2022;47(2):257-259. doi:10.1111/jcpt.13504
7. Oğuz E, et al. Activation-induced cytidine deaminase expression in patients with chronic myeloid leukemia Experimed. 2022;12(3):155-159
8. Oğuz E, et al. Evaluation of patients receiving immunosuppressive treatment among COVID-19 cases followed at a tertiary care hospital. Klimik Journal. 2022
INTERNATIONAL CONGRESS PRESENTATIONS (ACR)
9. Oğuz E, et al. Classification of idiopathic inflammatory myopathies: Assessment according to 2017 ACR/EULAR criteria. Arthritis Rheumatol. 2018;70(Suppl 9)
10. Oğuz E, et al. Favourable response to rituximab in IgG4-related disease: Long-term follow-up. Arthritis Rheumatol. 2018;70(Suppl 9)
11. Bektaş M, et al., Oğuz E. PET imaging in idiopathic inflammatory myositis: A case-control study. Arthritis Rheumatol. 2021;73(Suppl 9)
12. Toz B, et al., Oğuz E. IL-1 inhibitors in FMF-associated amyloidosis: Retrospective analysis. Arthritis Rheumatol. 2016;68(Suppl 10